Appointed CEO has Purchased Shares in Stille

Stille AB reports that Torbjörn Sköld, incoming CEO starting March 20th, 2023, purchased 8,770 shares in Stille on January 31st, 2023. The shares were purchased at 114 SEK per share, with a total value of 997,780 SEK.

Torshälla, February 2nd, 2023.

For more information, please contact:

Niklas Carlén
Interim CEO and President
+46 (0)73 087 49 70 | niklas.carlen@stille.se

Stille AB (publ) publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures. the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality. The share is listed on First North Growth Market under the acronym “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. For more information, visit www.stille.se.